Europe’s largest independent cannabis company

Medical Cannabis

Cannabis-based products for medical use

Thanks to deep scientific expertise, rigorous process management and quality control, EMMAC ensures MHRA medical-grade quality products with the full accreditation of relevant regulatory certifications for its manufacturing, distribution and supply processes.


Cutting-edge research

In partnership with leading European academic institutions including Imperial College London, EMMAC is at the forefront of research to deliver clinical data regarding the efficacy of medical cannabis for pain and the potential health benefits for patients.


End-to-end control

At EMMAC Life Sciences Group, we control the entire lifecycle of our medical cannabis – from cultivation and extraction to production and distribution.

Leadership & Expertise

People & expertise

EMMAC’s board and management team comprise of seasoned industry executives and consultants. Every member brings with them a wealth of knowledge and experience – from a range of scientific, medical, technical and FMCG backgrounds.

Imperial College London EMMAC

EMMAC announces pioneering research collaboration with Imperial College London

The partnership between EMMAC and Imperial College London has been forged to deliver a long-term comprehensive research programme designed to shape the future of the medical cannabis therapeutic industry.

EMMAC Across Europe

EMMAC has developed unique supply and distribution partnerships across Europe to establish itself not only as a thought leader at the very forefront of research into the medical benefits of cannabis but also a European leader in the production and supply of medical cannabis, hemp and other derivative products.

Press Releases

Stay informed

Fill in the form below to receive the latest news and developments in medical cannabis from EMMAC

Sign up for Updates
Privacy *
You may opt out at any time. For more information please read our Privacy Policy